LD-2 disclosure · 1st Quarter - Report
ABBVIE INC.
via ABBVIE, INC.
Client
- Name
- ABBVIE INC.
- Location
- District of Columbia · United States of America
Registrant
- Firm
- ABBVIE, INC.
- Description
- Biopharmaceutical company
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesCopyright/Patent/Trademark
S. 1096, Preserve Access to Affordable Generics and Biosimilars Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
S. 864, HELP Copays Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program and smoothing out-of-pocket costs for patients Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment
LobbyistsSTEPHEN SCANGO · DANIEL BACHNER · DORCAS ADEKUNLE · CRYSTAL RILEY · RACHEL DERBY